Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cutaneous lymphomas: which pathological classification?

H Miles Prince1, Rod O'Keefe, Christopher McCormack

  • 1Division of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia. mprince@petermac.unimelb.edu.au

Pathology
|March 21, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Agitated Saline Contrast Echocardiography in the diagnosis of right to left shunts: Guidance and recommendations from the British Society of Echocardiography.

Echo research and practice·2026
Same author

Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman disease.

Internal medicine journal·2026
Same author

Acceptance and Commitment Therapy for Psychosocial Outcomes in Children and Young People with Long-Term Physical Health Conditions: Systematic Review of Intervention Studies.

Children (Basel, Switzerland)·2026
Same author

Early-Life Exposures and Risk of Multiple Myeloma: A Population-Based Case-Control Study in Australia.

International journal of cancer·2026
Same author

Diet and risk of multiple myeloma: findings from a case-control study.

The British journal of nutrition·2026
Same author

Innovative approaches for managing relapsed or refractory peripheral T-cell lymphoma.

Expert opinion on pharmacotherapy·2026
Same journal

Impact of the 2025 Endocrine Society clinical practice guideline on the diagnosis and management of primary aldosteronism for the clinical laboratory.

Pathology·2026
Same journal

Cribriform intraductal carcinoma of the prostate may have a greater prognostic impact even than Gleason grade 5 conventional prostatic adenocarcinoma.

Pathology·2026
Same journal

Bordetella pertussis: emerging epidemiology, diagnosis and management.

Pathology·2026
Same journal

Development and validation of a real-time polymerase chain reaction for the detection of Haycocknema perplexum.

Pathology·2026
Same journal

Recent advances in the understanding of TP53 in haematological malignancies.

Pathology·2026
Same journal

Concurrent renal amyloid light chain amyloidosis, light chain crystalline podocytopathy and light chain proximal tubulopathy: a case report.

Pathology·2026
See all related articles

Primary cutaneous lymphomas, predominantly T-cell subtypes, arise from the skin. The World Health Organization (WHO) classification is recommended for categorizing these rare conditions for better unification.

Area of Science:

  • Dermatology
  • Hematology
  • Pathology

Background:

  • Cutaneous lymphomas are rare neoplasms primarily affecting the skin.
  • These disorders predominantly involve T-cell subtypes and present a diverse range of conditions.
  • Current classification systems (REAL, EORTC, WHO) for cutaneous lymphomas have limitations.

Purpose of the Study:

  • To recommend a unified approach for classifying primary cutaneous lymphomas.
  • To advocate for the adoption of the World Health Organization (WHO) classification system.

Main Methods:

  • Review and comparison of existing classification systems for cutaneous lymphomas.
  • Analysis of the strengths and weaknesses of the REAL, EORTC, and WHO classifications.

Main Results:

Related Experiment Videos

  • The WHO classification is deemed the most comprehensive and suitable for categorizing cutaneous lymphomas.
  • The WHO classification aligns cutaneous lymphomas with systemic lymphoproliferative disorders, promoting consistency.

Conclusions:

  • Pathologists should prioritize using the WHO classification for primary cutaneous lymphomas.
  • Adopting the WHO classification facilitates a unified understanding and consistent categorization of these rare skin cancers.